參考文獻(xiàn)/References:
[1] The Asia Pacific COPD Round table Group.Global initiative for chronic obstructive lung disease strategy for the diagnosis,management and prevention of chronic obstructive pulmonary disease:An Asia-Pacific perspective[J].Respirology,2010,10（1）：9-17.
[2] BURAN CIRAK Y,YILMAZ YELVAR G D,DURUSTKAN E N.Effectiveness of 12-week inspiratory muscle training with manual therapy in patients with COPD：a randomized controlled study[J].Clin Respir J,2022,16(4):317-328.
[3] 周俊,陶珍,李浩.膈肌增厚分?jǐn)?shù)對(duì)機(jī)械通氣慢性阻塞性肺疾病患者撤機(jī)的指導(dǎo)價(jià)值觀察[J].臨床醫(yī)學(xué)工程,2019,26(6):725-726.
[4] AMIN A,ZEDAN M.Transthoracic ultrasonographic evalua-tion of diaphragmatic excursion in patients with chronic obstructive pulmonary disease[J].Egyptian Journal of Bronchology,2018,12：27-32.
[5] RITTAYAMAI N,CHUAYCHOO B,TSCHEIKUNA J,et al.Ultrasound evaluation of diaphragm force reserve in patients with chronic obstructive pulmonary disease[J].Ann Am Thorac Soc,2020,17(10):1222-1230.
[6] TEI C,LING L H,HODGE D O,et al.New index of combined systolic and diastolic myocardial performance：a simple and reproducible measure of cardiac function—a study in normals and dilated cardiomyopathy[J].J Cardiol,1995,26(6):357-366.
[7] 莫展,賴玉瓊,王飛.Tei指數(shù)評(píng)價(jià)肺動(dòng)脈高壓患者右心功能的臨床價(jià)值[J].現(xiàn)代醫(yī)用影像學(xué),2019,28(10):2323-2324.
相似文獻(xiàn)/References:
[1]劉雪君,佘暉,鄭玲容,等.BRD4抑制劑JQ1對(duì)慢性阻塞性肺疾病模型小鼠肺功能的影響[J].福建醫(yī)藥雜志,2022,44(01):107.
LIU Xuejun,SHE Hui,ZHENG Lingrong,et al.Effect of BRD4 inhibitor JQ1 on lung function in mice with chronic obstructive pulmonary disease[J].FUJIAN MEDICAL JOURNAL,2022,44(01):107.
[2]陳新旺,薛聃,黃崢慧,等.慢性阻塞性肺疾病對(duì)肺癌患者免疫治療相關(guān)性肺炎風(fēng)險(xiǎn)影響的Meta分析[J].福建醫(yī)藥雜志,2022,44(06):25.
CHEN Xinwang,XUE Dan,HUANG Zhenghui,et al.Impact of chronic obstructive pulmonary disease on risk of immune checkpoint inhibitor pneumonitis in patients with lung cancer: a meta-analysis[J].FUJIAN MEDICAL JOURNAL,2022,44(01):25.